Oral anticoagulant/platelet inhibitor low dose formulation

Details Oral anticoagulant/platelet inhibitor low dose formulation Oral anticoagulant/platelet inhibitor low dose formulation

A - Human Necessities

61

K

A61K 31/54 (2006.01) A61K 31/35 (2006.01) A61K 31/40 (2006.01) A61K 31/44 (2006.01) A61K 31/45 (2006.01) A61K 31/62 (1990.01)

Patent

CA 2065347

2065347 9104031 PCTABS00003 There are disclosed combination products useful for the treatment and/or prevention of a first or recurrent myocardial infarction or a first or recurrent stroke. Said combination products comprise low doses of an oral anticoagulant, preferably warfarin and platelet inhibiting agents, including non-steroidal antiinflammatory agents and preferably aspirin.

Affiliated with

Also associated with

Rating

Oral anticoagulant/platelet inhibitor low dose formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral anticoagulant/platelet inhibitor low dose formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral anticoagulant/platelet inhibitor low dose formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1734798